
CPHI Milan 2026
10/2026 – 10/2026
Simcere Pharmaceutical Group Limited (stock code 2096.HK) is a pharmaceutical company driven by innovative R&D, committed to providing today's patients with the medicines of the future across core therapeutic areas including oncology, central nervous system, autoimmunity and anti-infection, while actively expanding into disease areas with significant unmet clinical needs.

暂无评论。
留下您的评分和评论